Goldman Sachs lifted their price target on shares of Bodycote (LON: BOY) from $7.22 (480 GBX) to $7.52 (500 GBX) in a research note issued on Tuesday. The firm currently has a “neutral” rating on the stock.
A number of other analysts have also recently weighed in on BOY. Analysts at Bank of America raised their price target on shares of Bodycote from $6.90 to $7.35 in a research note to investors on Thursday, February 28th. They now have an “underperform” rating on the stock. Separately, analysts at Numis Securities Ltd reiterated an “add” rating on shares of Bodycote in a research note to investors on Wednesday, February 27th. They now have a $8.49 price target on the stock. Finally, analysts at N+1 Singer reiterated a “hold” rating on shares of Bodycote in a research note to investors on Wednesday, February 27th. They now have a $6.07 price target on the stock.
Shares of Bodycote opened at 547.50 on Tuesday. Bodycote has a 52 week low of GBX 300.50 and a 52 week high of GBX 556.50. The stock’s 50-day moving average is currently GBX 384.0. The company’s market cap is £1.032 billion.
Bodycote plc (Bodycote) is a specialized plasma spray, high velocity oxy fuel (HVOF) and thermally formed ceramic treatments.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
